News Focus
News Focus
Replies to #6110 on Biotech Values
icon url

DewDiligence

12/25/04 10:14 PM

#6112 RE: rstor1 #6110

>>Will their trials be smaller or less costly?<<

Presumably, yes. This is the reason for going the 505(b)(2) route.